vs

Side-by-side financial comparison of CALAVO GROWERS INC (CVGW) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

CALAVO GROWERS INC is the larger business by last-quarter revenue ($124.7M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). CALAVO GROWERS INC runs the higher net margin — 3.1% vs -38.1%, a 41.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -26.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -1.2%).

Calavo Growers, Inc. is an international consumer goods and farm products company. It packages, and distributes avocados and other fruits, as well as their fresh prepared food to restaurants, stores, and individual customers worldwide.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CVGW vs PRCT — Head-to-Head

Bigger by revenue
CVGW
CVGW
1.5× larger
CVGW
$124.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+46.8% gap
PRCT
20.2%
-26.6%
CVGW
Higher net margin
CVGW
CVGW
41.1% more per $
CVGW
3.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-1.2%
CVGW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVGW
CVGW
PRCT
PRCT
Revenue
$124.7M
$83.1M
Net Profit
$3.8M
$-31.6M
Gross Margin
9.3%
64.9%
Operating Margin
-1.4%
-4.1%
Net Margin
3.1%
-38.1%
Revenue YoY
-26.6%
20.2%
Net Profit YoY
2846.0%
-27.9%
EPS (diluted)
$0.22
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVGW
CVGW
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$124.7M
$76.4M
Q3 25
$178.8M
$83.3M
Q2 25
$190.5M
$79.2M
Q1 25
$154.4M
$69.2M
Q4 24
$170.0M
$68.2M
Q3 24
$179.6M
$58.4M
Q2 24
$184.4M
$53.4M
Net Profit
CVGW
CVGW
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$3.8M
$-29.8M
Q3 25
$4.7M
$-21.4M
Q2 25
$6.8M
$-19.6M
Q1 25
$4.4M
$-24.7M
Q4 24
$-139.0K
$-18.9M
Q3 24
$-732.0K
$-21.0M
Q2 24
$6.1M
$-25.6M
Gross Margin
CVGW
CVGW
PRCT
PRCT
Q1 26
64.9%
Q4 25
9.3%
60.6%
Q3 25
10.2%
64.8%
Q2 25
9.5%
65.4%
Q1 25
10.2%
63.9%
Q4 24
9.7%
64.0%
Q3 24
11.2%
63.2%
Q2 24
11.1%
59.0%
Operating Margin
CVGW
CVGW
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-1.4%
-40.6%
Q3 25
4.8%
-27.8%
Q2 25
4.0%
-28.0%
Q1 25
3.3%
-39.7%
Q4 24
1.8%
-28.9%
Q3 24
5.2%
-38.4%
Q2 24
4.0%
-50.3%
Net Margin
CVGW
CVGW
PRCT
PRCT
Q1 26
-38.1%
Q4 25
3.1%
-39.1%
Q3 25
2.6%
-25.7%
Q2 25
3.6%
-24.7%
Q1 25
2.9%
-35.8%
Q4 24
-0.1%
-27.6%
Q3 24
-0.4%
-35.9%
Q2 24
3.3%
-48.0%
EPS (diluted)
CVGW
CVGW
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.22
$-0.54
Q3 25
$0.26
$-0.38
Q2 25
$0.38
$-0.35
Q1 25
$0.25
$-0.45
Q4 24
$-0.01
$-0.34
Q3 24
$-0.04
$-0.40
Q2 24
$0.34
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVGW
CVGW
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$61.2M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$206.9M
$347.7M
Total Assets
$292.2M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVGW
CVGW
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$61.2M
$286.5M
Q3 25
$63.8M
$294.3M
Q2 25
$60.4M
$302.7M
Q1 25
$48.5M
$316.2M
Q4 24
$57.0M
$333.7M
Q3 24
$1.1M
$196.8M
Q2 24
$4.3M
$214.1M
Total Debt
CVGW
CVGW
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CVGW
CVGW
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$206.9M
$365.9M
Q3 25
$206.4M
$380.3M
Q2 25
$206.6M
$385.8M
Q1 25
$202.9M
$389.2M
Q4 24
$200.3M
$402.2M
Q3 24
$205.2M
$241.2M
Q2 24
$207.3M
$251.8M
Total Assets
CVGW
CVGW
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$292.2M
$508.1M
Q3 25
$301.2M
$511.5M
Q2 25
$321.5M
$513.1M
Q1 25
$298.9M
$519.4M
Q4 24
$301.1M
$534.0M
Q3 24
$382.4M
$374.1M
Q2 24
$411.4M
$374.4M
Debt / Equity
CVGW
CVGW
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVGW
CVGW
PRCT
PRCT
Operating Cash FlowLast quarter
$2.3M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
1.0%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
0.60×
TTM Free Cash FlowTrailing 4 quarters
$19.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVGW
CVGW
PRCT
PRCT
Q1 26
Q4 25
$2.3M
$-10.3M
Q3 25
$8.0M
$-6.6M
Q2 25
$15.7M
$-15.0M
Q1 25
$-4.4M
$-17.0M
Q4 24
$10.8M
$-32.4M
Q3 24
$11.4M
$-18.8M
Q2 24
$2.1M
$-15.7M
Free Cash Flow
CVGW
CVGW
PRCT
PRCT
Q1 26
Q4 25
$1.2M
$-12.2M
Q3 25
$7.3M
$-9.5M
Q2 25
$15.6M
$-17.8M
Q1 25
$-4.7M
$-18.8M
Q4 24
$10.5M
$-33.6M
Q3 24
$11.3M
$-19.0M
Q2 24
$745.0K
$-16.8M
FCF Margin
CVGW
CVGW
PRCT
PRCT
Q1 26
Q4 25
1.0%
-15.9%
Q3 25
4.1%
-11.4%
Q2 25
8.2%
-22.5%
Q1 25
-3.1%
-27.2%
Q4 24
6.2%
-49.2%
Q3 24
6.3%
-32.6%
Q2 24
0.4%
-31.4%
Capex Intensity
CVGW
CVGW
PRCT
PRCT
Q1 26
Q4 25
0.9%
2.4%
Q3 25
0.4%
3.4%
Q2 25
0.1%
3.5%
Q1 25
0.2%
2.7%
Q4 24
0.2%
1.7%
Q3 24
0.1%
0.4%
Q2 24
0.7%
2.0%
Cash Conversion
CVGW
CVGW
PRCT
PRCT
Q1 26
Q4 25
0.60×
Q3 25
1.69×
Q2 25
2.29×
Q1 25
-1.00×
Q4 24
Q3 24
Q2 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVGW
CVGW

Fresh Products$104.7M84%
Segment Prepared$14.5M12%
Tomatoes$4.6M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons